Steigerwald, Ilona <br/><br/>
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.  [electronic resource] 

 -  Current medical research and opinion  Jun 2012 
 - 911-36 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2012.679254  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analgesics--administration & dosage<br/>Chronic Pain--complications<br/>Delayed-Action Preparations--administration & dosage<br/>Female<br/>Humans<br/>Low Back Pain--complications<br/>Male<br/>Middle Aged<br/>Neuralgia--complications<br/>Phenols--administration & dosage<br/>Quality of Life<br/>Severity of Illness Index<br/>Tapentadol<br/>Treatment Outcome<br/>Assessment of Medication Adherence